{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:34:00Z","timestamp":1740123240650,"version":"3.37.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26430043","18K06511","17082006","42890001"],"award-info":[{"award-number":["26430043","18K06511","17082006","42890001"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11064-020-03086-z","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:05:31Z","timestamp":1594289131000},"page":"2286-2301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Wenting","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-7087","authenticated-orcid":false,"given":"Toshio","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"3086_CR1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson's disease. J Neurochem 139:318\u2013324","journal-title":"J Neurochem"},{"issue":"23","key":"3086_CR2","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1742-4658.2010.07896.x","volume":"277","author":"T Alberio","year":"2010","unstructured":"Alberio T, Bossi AM, Milli A, Parma E, Gariboldi MB, Tosi G, Lopiano L, Fasano M (2010) Proteomic analysis of dopamine and \u03b1-synuclein interplay in a cellular model of Parkinson\u2019s disease pathogenesis. FEBS J 277(23):4909\u20134919","journal-title":"FEBS J"},{"issue":"6","key":"3086_CR3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G (2010) Missing pieces in the Parkinson's disease puzzle. Nat Med 16(6):653","journal-title":"Nat Med"},{"issue":"12","key":"3086_CR4","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS (2007) Involvement of interferon-\u03b3 in microglial-mediated loss of dopaminergic neurons. J Neurosci 27(12):3328\u20133337","journal-title":"J Neurosci"},{"issue":"4","key":"3086_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397","journal-title":"Lancet Neurol"},{"issue":"2","key":"3086_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D Blum","year":"2001","unstructured":"Blum D, Torch S, Lambeng N, Nissou MF, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65(2):135\u2013172","journal-title":"Prog Neurobiol"},{"issue":"1","key":"3086_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0361-9230(78)90065-5","volume":"3","author":"N Rowland","year":"1978","unstructured":"Rowland N (1978) Meal patterns in rats with nigrostriatal dopamine-depleting lesions, subdiaphragmatic vagotomy, and their combination. Brain Res Bull 3(1):89\u201391","journal-title":"Brain Res Bull"},{"issue":"2","key":"3086_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0091-3057(80)90353-6","volume":"12","author":"F Hefti","year":"1980","unstructured":"Hefti F, Melamed E, Sahakian BJ, Wurtman RJ (1980) Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav 12(2):185\u2013188","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"3086_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/MN:28:1:51","volume":"28","author":"E Charrier","year":"2003","unstructured":"Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J (2003) Collapsin response mediator proteins (CRMPs). Mol Neurobiol 28(1):51\u201363","journal-title":"Mol Neurobiol"},{"issue":"7","key":"3086_CR10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1523\/JNEUROSCI.5055-06.2007","volume":"27","author":"YZ Alabed","year":"2007","unstructured":"Alabed YZ, Pool M, Tone SO, Fournier AE (2007) Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition. J Neurosci 27(7):1702\u20131711","journal-title":"J Neurosci"},{"key":"3086_CR11","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1038\/srep08269","volume":"5","author":"J Nagai","year":"2015","unstructured":"Nagai J, Kitamura Y, Owada K, Yamashita N, Takei K, Goshima Y, Ohshima T (2015) Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation. Sci Rep 5:8269","journal-title":"Sci Rep"},{"key":"3086_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/947423","author":"M Tan","year":"2015","unstructured":"Tan M, Cha C, Ye Y, Zhang J, Li S, Wu F, Gong S, Guo G (2015) CRMP4 and CRMP2 interact to coordinate cytoskeleton dynamics, regulating growth cone development and axon elongation. Neural Plast. https:\/\/doi.org\/10.1155\/2015\/947423","journal-title":"Neural Plast"},{"issue":"5","key":"3086_CR13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/jnc.13617","volume":"137","author":"A Tonouchi","year":"2016","unstructured":"Tonouchi A, Nagai J, Togashi K, Goshima Y, Ohshima T (2016) Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson's disease. J Neurochem 137(5):795\u2013805","journal-title":"J Neurochem"},{"issue":"11","key":"3086_CR14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/dneu.22007","volume":"72","author":"E Niisato","year":"2012","unstructured":"Niisato E, Nagai J, Yamashita N, Abe T, Kiyonari H, Goshima Y, Ohshima T (2012) CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus. Dev Neurobiol 72(11):1447\u20131457","journal-title":"Dev Neurobiol"},{"key":"3086_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","volume":"36","author":"F Morroni","year":"2013","unstructured":"Morroni F, Tarozzi A, Sita G, Bolondi C, Moraga JMZ, Cantelli-Forti G, Hrelia P (2013) Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. Neurotoxicology 36:63\u201371","journal-title":"Neurotoxicology"},{"issue":"6","key":"3086_CR16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/ejn.12459","volume":"39","author":"SR Stott","year":"2014","unstructured":"Stott SR, Barker RA (2014) Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease. Eur J Neurosci 39(6):1042\u20131056","journal-title":"Eur J Neurosci"},{"issue":"1","key":"3086_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","volume":"162","author":"R Iancu","year":"2005","unstructured":"Iancu R, Mohapel P, Brundin P, Paul G (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162(1):1\u201310","journal-title":"Behav Brain Res"},{"issue":"19","key":"3086_CR18","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.191107398","volume":"98","author":"H Mochizuki","year":"2001","unstructured":"Mochizuki H, Hayakawa H, Migita M, Shibata M, Tanaka R, Suzuki A, Shimo-Nakanishi Y, Urabe T, Yamada M, Tamayose K, Shimada T (2001) An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc Natl Acad Sci 98(19):10918\u201310923","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"3086_CR19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11064-013-1005-4","volume":"38","author":"J Prakash","year":"2013","unstructured":"Prakash J, Yadav SK, Chouhan S, Singh SP (2013) Neuroprotective role of Withania somnifera root extract in Maneb\u2013Paraquat induced mouse model of parkinsonism. Neurochem Res 38(5):972\u2013980","journal-title":"Neurochem Res"},{"issue":"8","key":"3086_CR20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuint.2013.03.015","volume":"62","author":"SK Yadav","year":"2013","unstructured":"Yadav SK, Prakash J, Chouhan S, Singh SP (2013) Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model. Neurochem Int 62(8):1039\u20131047","journal-title":"Neurochem Int"},{"issue":"7","key":"3086_CR21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671","journal-title":"Nat Methods"},{"issue":"11","key":"3086_CR22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"VL Feigin","year":"2017","unstructured":"Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, Abyu GY, Ahmed MB, Aichour AN, Aichour I, Aichour MTE (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877\u2013897","journal-title":"Lancet Neurol"},{"issue":"2","key":"3086_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-4886(03)00363-7","volume":"185","author":"G Paul","year":"2004","unstructured":"Paul G, Meissner W, Rein S, Harnack D, Winter C, Hosmann K, Morgenstern R, Kupsch A (2004) Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol 185(2):272\u2013280","journal-title":"Exp Neurol"},{"issue":"2","key":"3086_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","volume":"25","author":"F Blandini","year":"2007","unstructured":"Blandini F, Levandis G, Bazzini E, Nappi G, Armentero MT (2007) Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 25(2):397\u2013405","journal-title":"Eur J Neurosci"},{"issue":"2\u20133","key":"3086_CR25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12035-010-8118-4","volume":"41","author":"M McCollum","year":"2010","unstructured":"McCollum M, Ma Z, Cohen E, Leon R, Tao R, Wu JY, Maharaj D, Wei J (2010) Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson\u2019s disease. Mol Neurobiol 41(2\u20133):410\u2013419","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3086_CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbr.2008.12.007","volume":"199","author":"A Klein","year":"2009","unstructured":"Klein A, Wessolleck J, Papazoglou A, Metz GA, Nikkhah G (2009) Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats. Behav Brain Res 199(2):317\u2013325","journal-title":"Behav Brain Res"},{"issue":"1","key":"3086_CR27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","volume":"1101","author":"MDMS Lima","year":"2006","unstructured":"Lima MDMS, Reksidler AB, Zanata SM, Machado HB, Tufik S, Vital MA (2006) Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. Brain Res 1101(1):117\u2013125","journal-title":"Brain Res"},{"issue":"9","key":"3086_CR28","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, Vila M, Jackson-Lewis V, Przedborski S (2003) Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci 100(9):5473\u20135478","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"3086_CR29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1471-4159.2009.06394.x","volume":"111","author":"A Tarozzi","year":"2009","unstructured":"Tarozzi A, Morroni F, Merlicco A, Hrelia S, Angeloni C, Cantelli-Forti G, Hrelia P (2009) Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. J Neurochem 111(5):1161\u20131171","journal-title":"J Neurochem"},{"issue":"5","key":"3086_CR30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76(5):1265\u20131274","journal-title":"J Neurochem"},{"issue":"10","key":"3086_CR31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s003359900551","volume":"8","author":"DC Rogers","year":"1997","unstructured":"Rogers DC, Fisher EMC, Brown SDM, Peters J, Hunter AJ, Martin JE (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8(10):711\u2013713","journal-title":"Mamm Genome"},{"issue":"1\u20132","key":"3086_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(01)01885-7","volume":"306","author":"DC Rogers","year":"2001","unstructured":"Rogers DC, Peters JO, Martin JE, Ball S, Nicholson SJ, Witherden AS, Hafezparast M, Latcham J, Robinson TL, Quilter CA, Fisher EM (2001) SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci Lett 306(1\u20132):89\u201392","journal-title":"Neurosci Lett"},{"issue":"11","key":"3086_CR33","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1460-9568.2000.00274.x","volume":"12","author":"D Kirik","year":"2000","unstructured":"Kirik D, Rosenblad C, Bj\u00f6rklund A (2000) Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur J Neurosci 12(11):3871\u20133882","journal-title":"Eur J Neurosci"},{"issue":"2","key":"3086_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/exnr.1994.1054","volume":"126","author":"J Thomas","year":"1994","unstructured":"Thomas J, Wang J, Takubo H, Sheng J, de Jesus S, Bankiewicz KS (1994) A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Exp Neurol 126(2):159\u2013167","journal-title":"Exp Neurol"},{"issue":"1","key":"3086_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.2000.7409","volume":"164","author":"JC Bensadoun","year":"2000","unstructured":"Bensadoun JC, D\u00e9glon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol 164(1):15\u201324","journal-title":"Exp Neurol"},{"issue":"2","key":"3086_CR36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/exnr.2002.7877","volume":"174","author":"LA Cunningham","year":"2002","unstructured":"Cunningham LA, Su C (2002) Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp Neurol 174(2):230\u2013242","journal-title":"Exp Neurol"},{"issue":"3","key":"3086_CR37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/neu.2006.0078","volume":"24","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Ottens AK, Sadasivan S, Kobeissy FH, Fang T, Hayes RL, Wang KK (2007) Calpain-mediated collapsin response mediator protein-1,-2, and-4 proteolysis after neurotoxic and traumatic brain injury. J Neurotrauma 24(3):460\u2013472","journal-title":"J Neurotrauma"},{"issue":"14","key":"3086_CR38","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/pmic.200800979","volume":"9","author":"W Liu","year":"2009","unstructured":"Liu W, Zhou XW, Liu S, Hu K, Wang C, He Q, Li M (2009) Calpain-truncated CRMP-3 and-4 contribute to potassium deprivation-induced apoptosis of cerebellar granule neurons. Proteomics 9(14):3712\u20133728","journal-title":"Proteomics"},{"issue":"5","key":"3086_CR39","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1074\/jbc.M210181200","volume":"278","author":"S Franken","year":"2003","unstructured":"Franken S, Junghans U, Rosslenbroich V, Baader SL, Hoffmann R, Gieselmann V, Viebahn C, Kappler J (2003) Collapsin response mediator proteins of neonatal rat brain interact with chondroitin sulfate. J Biol Chem 278(5):3241\u20133250","journal-title":"J Biol Chem"},{"issue":"2","key":"3086_CR40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yexcr.2005.08.005","volume":"310","author":"V Rosslenbroich","year":"2005","unstructured":"Rosslenbroich V, Dai L, Baader SL, Noegel AA, Gieselmann V, Kappler J (2005) Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res 310(2):434\u2013444","journal-title":"Exp Cell Res"},{"key":"3086_CR41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuroscience.2013.08.023","volume":"253","author":"J Manivannan","year":"2013","unstructured":"Manivannan J, Tay SSW, Ling EA, Dheen ST (2013) Dihydropyrimidinase-like 3 regulates the inflammatory response of activated microglia. Neuroscience 253:40\u201354","journal-title":"Neuroscience"},{"issue":"12","key":"3086_CR42","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.94.12.6500","volume":"94","author":"S Miettinen","year":"1997","unstructured":"Miettinen S, Fusco FR, Yrj\u00e4nheikki J, Kein\u00e4nen R, Hirvonen T, Roivainen R, N\u00e4rhi M, H\u00f6kfelt T, Koistinaho J (1997) Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci 94(12):6500\u20136505","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"3086_CR43","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.95.18.10966","volume":"95","author":"S Nogawa","year":"1998","unstructured":"Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C (1998) Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci 95(18):10966\u201310971","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"3086_CR44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/089771500415436","volume":"17","author":"KI Strauss","year":"2000","unstructured":"Strauss KI, Barbe MF, Marshall RM, Raghupathi R, Mehta S, Narayan RK (2000) Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. J Neurotrauma 17(8):695\u2013711","journal-title":"J Neurotrauma"},{"issue":"2","key":"3086_CR45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","volume":"11","author":"K Yamagata","year":"1993","unstructured":"Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11(2):371\u2013386","journal-title":"Neuron"},{"issue":"2","key":"3086_CR46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1471-4159.2001.00108.x","volume":"76","author":"JL Madrigal","year":"2001","unstructured":"Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Bosc\u00e1 L, Leza JC (2001) Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor \u03baB-mediated mechanisms. J Neurochem 76(2):532\u2013538","journal-title":"J Neurochem"},{"issue":"4","key":"3086_CR47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0893-133X(00)00208-6","volume":"24","author":"JL Madrigal","year":"2001","unstructured":"Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J, Leza JC (2001) Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24(4):420","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"3086_CR48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1046\/j.1460-9568.2003.02888.x","volume":"18","author":"JL Madrigal","year":"2003","unstructured":"Madrigal JL, Garc\u00eda-Bueno B, Moro MA, Lizasoain I, Lorenzo P, Leza JC (2003) Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress. Eur J Neurosci 18(6):1701\u20131705","journal-title":"Eur J Neurosci"},{"issue":"9","key":"3086_CR49","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/sj.npp.1300187","volume":"28","author":"JL Madrigal","year":"2003","unstructured":"Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Fern\u00e1ndez AP, Rodrigo J, Bosc\u00e1 L, Leza JC (2003) Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28(9):1579","journal-title":"Neuropsychopharmacology"},{"key":"3086_CR50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2013.02.027","volume":"1509","author":"KM Gerecke","year":"2013","unstructured":"Gerecke KM, Kolobova A, Allen S, Fawer JL (2013) Exercise protects against chronic restraint stress-induced oxidative stress in the cortex and hippocampus. Brain Res 1509:66\u201378","journal-title":"Brain Res"},{"issue":"2","key":"3086_CR51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-8993(02)03164-5","volume":"951","author":"JJ Hoozemans","year":"2002","unstructured":"Hoozemans JJ, Veerhuis R, Janssen I, van Elk EJ, Rozemuller AJ, Eikelenboom P (2002) The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E2 secretion by cultured human adult microglia: implications for Alzheimer\u2019s disease. Brain Res 951(2):218\u2013226","journal-title":"Brain Res"},{"issue":"9","key":"3086_CR52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63(9):901\u2013910","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"3086_CR53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1471-4159.1999.0730322.x","volume":"73","author":"BS Jeon","year":"1999","unstructured":"Jeon BS, Kholodilov NG, Oo TF, Kim SY, Tomaselli KJ, Srinivasan A, Stefanis L, Burke RE (1999) Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 73(1):322\u2013333","journal-title":"J Neurochem"},{"issue":"1","key":"3086_CR54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1471-4159.2006.03730.x","volume":"97","author":"M Ouyang","year":"2006","unstructured":"Ouyang M, Shen X (2006) Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 97(1):234\u2013244","journal-title":"J Neurochem"},{"issue":"7343","key":"3086_CR55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nature09788","volume":"472","author":"MA Burguillos","year":"2011","unstructured":"Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472(7343):319","journal-title":"Nature"},{"issue":"1","key":"3086_CR56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(02)03694-6","volume":"958","author":"MJ Mart\u00ed","year":"2002","unstructured":"Mart\u00ed MJ, Saura J, Burke RE, Jackson-Lewis V, Jim\u00e9nez A, Bonastre M, Tolosa E (2002) Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat. Brain Res 958(1):185\u2013191","journal-title":"Brain Res"},{"issue":"2","key":"3086_CR57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainres.2003.10.035","volume":"996","author":"A Mladenovi\u0107","year":"2004","unstructured":"Mladenovi\u0107 A, Perovi\u0107 M, Rai\u010devi\u0107 N, Kanazir S, Raki\u0107 L, Ru\u017ediji\u0107 S (2004) 6-Hydroxydopamine increases the level of TNF\u03b1 and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res 996(2):237\u2013245","journal-title":"Brain Res"},{"issue":"8","key":"3086_CR58","doi-asserted-by":"crossref","first-page":"e70951","DOI":"10.1371\/journal.pone.0070951","volume":"8","author":"D Hernandez-Baltazar","year":"2013","unstructured":"Hernandez-Baltazar D, Mendoza-Garrido ME, Martinez-Fong D (2013) Activation of GSK-3\u03b2 and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine. PLoS ONE 8(8):e70951","journal-title":"PLoS ONE"},{"issue":"2\u20133","key":"3086_CR59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000346155","volume":"35","author":"JL Venero","year":"2013","unstructured":"Venero JL, Burguillos MA, Joseph B (2013) Caspases playing in the field of neuroinflammation: old and new players. Dev Neurosci 35(2\u20133):88\u2013101","journal-title":"Dev Neurosci"},{"issue":"4","key":"3086_CR60","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang XIA, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases. Mol Med Rep 13(4):3391\u20133396","journal-title":"Mol Med Rep"},{"issue":"8","key":"3086_CR61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0165-6147(03)00176-7","volume":"24","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS (2003) Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 24(8):395\u2013401","journal-title":"Trends Pharmacol Sci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-020-03086-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:32:20Z","timestamp":1625787140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-020-03086-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03086-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Waseda University (2017-A027, 2018-A003, 2019-A025).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}